MSKCC | Parker Institute for Cancer Immunotherapy
@PICIatMSK
Followers
760
Following
789
Media
3
Statuses
330
The @parkerici group at @MSKCancerCenter works to accelerate the development of breakthrough immune therapies capable of turning cancer into a curable disease.
New York, NY
Joined July 2020
RT @vandenBrinkLab: So proud of @dewolf_susan and team for this incredible paper! .
science.org
T cell receptor sequencing reveals tissue-specific features of the posttransplant T cell repertoire in mouse and human.
0
10
0
RT @vandenBrinkLab: We are so proud to share the incredible work of Chi Nguyen and her coauthors that was published in @CellCellPress .http….
0
8
0
RT @MSK_RadOnc: New in @NatureCancer from @MSKCancerCenter Drs Chris Barker and @xrtGenomics: Combining #radiotherapy with activation of ma….
0
15
0
RT @MSKCancerCenter: A combination of checkpoint inhibitor #immunotherapy drugs (nivolumab & relatlimab) given before #melanoma surgery sho….
mskcc.org
Results from a phase 2 clinical trial report a combination of two checkpoint inhibitor immunotherapy drugs given before melanoma surgery prevents this aggressive skin cancer from coming back. This...
0
5
0
RT @tsonipeled: Pleased to announce the opening of my lab at @MSKCancerCenter. Recruiting postdocs and at other levels. .
peledlab.org
The Peled Laboratory's website promotes a scientist's research.
0
37
0
RT @themis_brown: Very happy to share our study describing a new lineage of RORgt+ antigen presenting cells – Thetis cells – that instruct….
0
70
0
RT @DrMvandenBrink: Please let your young colleagues know about this great funding opportunity!
0
28
0
RT @MSKCancerCenter: Pancreatic cancer is one of the leading causes of cancer death in our nation. Thankfully, doctors at MSK are testing a….
mskcc.org
A vaccine using mRNA technology — the same technology used to create the COVID-19 vaccine — offers hope for preventing pancreatic cancer from returning after surgery.
0
9
0
RT @themis_brown: Thrilled to receive an @NIH @NIAIDNews DP2 New Innovator Award #NIHHighRisk to study newly identified Thetis cells in ear….
0
15
0
RT @parkerici: 🎉 Congratulations to.→ Parker Bridge Fellows, supported in partnership with @TheVFoundation @CampKatiee @KenHu77 @OldridgeDe….
0
1
0
RT @MSKCancerCenter: Our own @UshmaNeill said it best – summer internship season is our favorite time of year! On this #NationalInternDay,….
0
3
0
RT @parkerici: 📺 Median life expectancy for someone with metastatic #melanoma has improved from 7 months to 6 years. “That doesn’t mean our….
0
4
0
RT @drsanjaygupta: Even before mRNA was used for a covid vaccine, researchers @BioNTech_Group were using the technology to develop customiz….
0
43
0
RT @MSKCancerCenter: 👏 RT and congratulate Dr. Jedd Wolchok (@wolchokj) who is the #ASCO22 David A. Karnofsky Memorial Award and Lecture r….
0
23
0
RT @tmhohl71: 1/ My exceptional ID colleague @mini_kamboj is the winner of the Willet F. Whitmore Award for Clinical Excellence @MSKCancerC….
0
4
0
RT @SantoshVardhana: I’m thrilled that the 3rd chapter of our explorations of #COVID19 in patients with cancer is out today in @Cancer_Cell….
cell.com
Lyudovyk et al. analyze immunological factors required for SARS-CoV-2 clearance in patients with cancer. They observe delayed viral clearance in patients with impaired humoral immunity despite broad...
0
29
0
RT @fumikochino: #FinancialToxicity: "This idea that #affordability is the barrier between someone getting a #cancer tx vs paying to keep t….
0
10
0
RT @MSK_DeptOfMed: Congratulations to our @MSKCancerCenter DoM colleagues who have been named recipients of the 2022 @ConquerCancerFd Caree….
0
8
0
RT @JExpMed: Neutrophil phenotypes and functions in cancer: A consensus statement . From @DanielaQuail, @Bristolneu….
0
54
0